Rahoto: Yunƙurin da faɗuwa da shahararrun magungunan ƙwayoyi a yayin cutar COVID-19
LatsaYaduwar labarin coronavirus ya canza rayuwar yau da kullun a duniya - kuma a duk faɗin Amurka Tare da yawancin kasuwancin da aka rufe na ɗan lokaci wasu kuma suka taƙaita damar zuwa ƙananan ƙananan masu siye, sayen halaye sun bambanta . Amurkawa suna adana kayayyaki a cikin kowane tsarin isar da sako ko tafiya zuwa shagon don iyakance bayyanar da COVID-19.
Yayinda cutar ta ke yaduwa, kuma masu bincike a duk duniya suna neman magani, ana samun spik a cikin bukatar wasu magunguna - sannan ga karanci. Abubuwan da ake buƙata suna haifar da wannan abin da ake buƙata ta hanyar zamantakewar al'umma da siyasa, gami da taƙaitaccen bayani game da Fadar White House da labarin gwajin magungunan asibiti don abin da zai iya tasiri don taimakawa bi da COVID-19 .
A cikin watanni biyu da suka gabata, tun lokacin da kwayar cutar ta fara yaduwa a cikin Amurka, SingleCare yayi nazarin tashin da faduwar magunguna uku da ke da nasaba da yiwuwar maganin coronavirus:
- Hydroxychloroquine
- Albuterol
- Famotidine
Wannan shine abin da ke faruwa a layin gaba a kantin magani.
* Canje-canje a cikin ƙarar da aka nuna dangane da tsarin makonni 6 farawa Janairu 5, 2020.
Hydroxychloroquine
Hydroxychloroquine (na asali) Takaddama ), da sauran magungunan chloroquine, sune magungunan rigakafi da na rigakafin cutar. Yawanci ana amfani dasu don magance yanayin mai kumburi, kamar lupus da rheumatoid arthritis, da kuma hana malaria.
Tun farkon cutar, an samu karuwar 227% na bukatar hydroxychloroquine (HCQ), da kuma karin 207% na bukatar maganin zazzabin cizon sauro, a cewar bayanan SingleCare. Sparar da ake buƙata ya dace da lokacin da Shugaba Trump ya ambata magunguna.
Ranar Mar. 19 , a karo na farko da shugaban kasa ya tattauna fa'idodin HCQ a jawabinsa na manema labarai, bayanan SingleCare ya nuna kusan sau shida buƙatar buƙatar maganin idan aka kwatanta da makonni shida na farkon shekara.
A ranar 13 ga Afrilu, Shugaba Trump ambaci miyagun ƙwayoyi a karo na ƙarshe a cikin bayanin manema labarai na Fadar White House.
A ranar 24 ga Afrilu , Hukumar Abinci da Magunguna (FDA) ta yi gargaɗi game da shan shan magani saboda yiwuwar manyan matsalolin rudu na zuciya. Bayan haka, bayanan SingleCare sun nuna raguwar bukatar hydroxychloroquine.
* Canje-canje a cikin ƙarar da aka nuna dangane da tsarin makonni 6 farawa Janairu 5, 2020
* Shugaba Trump ya ambaci tushe: CNN , Washington Post
Albuterol
Albuterol wani nau'in inhala ne wanda ke magance fitar numfashi, da numfashi, da tari, da kuma kirjin kirji wanda yake faruwa sakamakon cututtukan huhu, kamar asma, emphysema, da kuma cututtukan huhu da ke saurin toshewa. COVID-19 cuta ce ta numfashi wanda zai iya zama mafi haɗari ga waɗanda ke da matsaloli na numfashi na farko.
Bayanan SingleCare sun nuna karuwar 36% gaba daya a cikin bukatar magungunan hana yaduwar cuta da kuma bronchodilator tun farkon barkewar cutar. Mutanen da ke da yanayin numfashi sun sake cika ko siyan ƙarin magani don tabbatar da cewa an gudanar da alamomin da kyau-musamman idan ƙwayoyin cuta na coronavirus za su iya tsananta musu.
A cikin watan Maris , an sami karuwar 37% na bukatar albuterol sulfate idan aka kwatanta da Fabrairu na wannan shekara, a cewar bayanan SingleCare. A cikin makon Mar. 15 kadai, an sami ƙaruwar 25% na buƙatar albuterol.
Haɓakar cikin takardar sayen magani ta zo daidai da yanki karancin magani a ƙarshen Maris , wanda Asima da Allergy Foundation na Amurka suka ruwaito. FDA ta fahimci ƙarin buƙata kuma kwanan nan ya amince da sabon tsarin farko na amfani da sinadarin albuterol inhaler .
* Canje-canje a cikin ƙarar da aka nuna dangane da tsarin makonni 6 farawa Janairu 5, 2020
Famotidine
Famotidine shine asalin sunan ga antacid gama gari Pepcid . An yi amfani dashi don magance ƙwannafi daga rashin narkewar abinci, cututtukan reflux na gastroesophageal (GERD), da ulcers.
A ranar 26 ga Afrilu, kafafen yada labarai sun ruwaito cewa jihar New York na gudanar da gwajin asibiti na wannan shahararren maganin da ba a kan-kan-kan ba a matsayin zabin magani na COVID-19. Nan da nan bayan wannan labarin ya ɓace, bayanan SingleCare ya nuna ƙimar 60% na buƙatar maganin.
Tasirin COVID-19 akan shahararrun takardar sayan magani
A wasu lokuta marasa tabbas, dabi'a ce don so a shirya. Lokacin da mummunar cuta ke yawo, kasancewa cikin ƙoshin lafiya babban buri ne. Cutar da ke faruwa a yanzu ta haifar da wani yanayi na musamman-kwayar cutar na haifar da cuta mai yaɗuwa, kuma babu wani magani da aka tabbatar ban da masu rage zazzaɓi da kayan aikin numfashi, kamar masu iska.
Yayinda Amurkawa ke fahimtar duk wani abu da zai taimaka, an sami canje-canje masu mahimmanci a cikin ciko don magungunan ƙwayoyi tare da fa'idodi masu fa'ida don magance alamun COVID-19. Muna ba da shawarar ci gaba da bin FDA da CDC don sabon labarai da jagororin game da ci gaban COVID-19 da ingancin magunguna.
